Objective: Our review analyses the studies that have specifically compared the association iDPP4/metformin with glimepiride/metformin, both in second line pharmacotherapy of type 2 diabetes mellitus (DM2). Methods: Systematic literature review with a meta-analysis of clinical trials comparing glimepiride with any iDPP4, both used together with metformin as a second line treatment of DM2. The effectiveness variables used were as follows: %HbA1c variation, fasting plasma glucose variation, patients achieving the therapeutic objective of HbA1c <7%, treatment dropouts due to lack of effectiveness and rescue treatments needed. The safety variables included were as follows: weight variation at the end of treatment; presentation of any type of adv...
INTRODUCTION: Targeting glycated hemoglobin (HbA(1c)) levels below 7.0\% is considered a primary goa...
OBJECTIVE: To assess the efficacy and safety of dipeptidyl peptidase-4 (DPP-4) inhibitors compared w...
<p><b>Objective</b>: To evaluate the efficacy and safety of adding the once-weekly DPP-4 inhibitor o...
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder carrying an enormous bur...
Objective: In our study, the objective was to evaluate the effectiveness of glycemic control of Glim...
Background: To evaluate the comparison of clinical outcomes of sitagliptin +metformin and glimepirid...
Background: Metformin has been recommended as a first-line therapy for T2DM in many guidelines. Addi...
BACKGROUND : The increased prevalence of Type 2 DM leads to increased cardiovascular morbidity, dy...
Objectives: The objectives of this study was to compare the efficacy of Glimepiride+Metformin versus...
Background: Diabetes mellitus (DM) is a spectrum of metabolic disorders as a consequence of differen...
Background. The use of glimepiride in the therapy of type 2 diabetes mellitus (DM) fewer stimulates ...
Objective: Type 2 diabetes mellitus (DM) is a most common metabolic disorder. The present study aime...
Aim. To investigate the efficacy and safety of combined glimepiride and metformin therapy in patie...
Background. The early prescription of a combination of extended-release metformin with glimepiride i...
AbstractCombinational therapies are often required in the management of type 2 diabetes mellitus (T2...
INTRODUCTION: Targeting glycated hemoglobin (HbA(1c)) levels below 7.0\% is considered a primary goa...
OBJECTIVE: To assess the efficacy and safety of dipeptidyl peptidase-4 (DPP-4) inhibitors compared w...
<p><b>Objective</b>: To evaluate the efficacy and safety of adding the once-weekly DPP-4 inhibitor o...
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder carrying an enormous bur...
Objective: In our study, the objective was to evaluate the effectiveness of glycemic control of Glim...
Background: To evaluate the comparison of clinical outcomes of sitagliptin +metformin and glimepirid...
Background: Metformin has been recommended as a first-line therapy for T2DM in many guidelines. Addi...
BACKGROUND : The increased prevalence of Type 2 DM leads to increased cardiovascular morbidity, dy...
Objectives: The objectives of this study was to compare the efficacy of Glimepiride+Metformin versus...
Background: Diabetes mellitus (DM) is a spectrum of metabolic disorders as a consequence of differen...
Background. The use of glimepiride in the therapy of type 2 diabetes mellitus (DM) fewer stimulates ...
Objective: Type 2 diabetes mellitus (DM) is a most common metabolic disorder. The present study aime...
Aim. To investigate the efficacy and safety of combined glimepiride and metformin therapy in patie...
Background. The early prescription of a combination of extended-release metformin with glimepiride i...
AbstractCombinational therapies are often required in the management of type 2 diabetes mellitus (T2...
INTRODUCTION: Targeting glycated hemoglobin (HbA(1c)) levels below 7.0\% is considered a primary goa...
OBJECTIVE: To assess the efficacy and safety of dipeptidyl peptidase-4 (DPP-4) inhibitors compared w...
<p><b>Objective</b>: To evaluate the efficacy and safety of adding the once-weekly DPP-4 inhibitor o...